Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

December 25, 2024

Conditions

Herpetic Keratitis

Interventions

DRUG

Acyclovir 400 MG

Acyclovir is used to treat infections caused by certain types of viruses.

DRUG

Ganciclovir (GCV)

Ganciclovir is an anti-viral drug

Trial Locations (1)

Al-Azhar university, Damietta

All Listed Sponsors

lead

Al-Azhar University

OTHER

NCT06757907 - Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis | Biotech Hunter | Biotech Hunter